(Total Views: 53)
Posted On: 11/07/2019 9:25:18 AM
Post# of 44089
$BNGI BANGI is a diversified investment vehicle that acquires and leases specialized real estate assets, including cannabis farms, dispensaries, commercial real estate, industrial real estate, and leasing real estate to the multi-billion dollar and growing cannabis industry. Our success is primarily driven by the lack of financing for real estate in the cannabis industry. This is primarily due to federal regulations on cannabis which have prevented the banking industry-anchored in federal regulations- from financing cannabis companies, which leaves an enormous opportunity for alternative solutions such as ours. As one of the only publicly-traded companies in the cannabis sector focused on acquiring and leasing real estate to the industry, BANGI is prepared to meet this opportunity with a formula for success.
According to ArcView Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry will see much progress around the globe. Spending on legal cannabis worldwide is expected to hit $57 billion by 2027. The adult-use (recreational) market will cover 67% of the spending; medical marijuana will take up the remaining 33%.
The largest group of cannabis buyers will be in North America, going from $9.2 billion in 2017 to $47.3 billion a decade later. The largest growth spread, however, is predicted within the rest-of-world markets, from $52 million spent in 2017 to a projected $2.5 billion in 2027.
The worldwide adult recreational cannabis market remains hampered by the United Nations and its 1961 Single Convention on Narcotic Drugs. The ArcView and BDS report believe nothing will be done to change the U.N. attitude until U.S. federal laws legalize marijuana — something Arcview’s CEO, Troy Dayton, believes will happen after the 2020 presidential election.
Still, the main difference between the U.S. and European cannabis markets is that in the U.S., recreational use will dominate sales. With a budget of $1.3 trillion in health care spending, European government-subsidized health care systems will bring the medical cannabis market to dominate Europe and become the largest medical marijuana market in the world.
BANGI believes that the future belongs to those who are keen on capitalizing on the biggest growth trends. We invite you to join us in capitalizing on the fastest growing industry in America.
According to ArcView Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry will see much progress around the globe. Spending on legal cannabis worldwide is expected to hit $57 billion by 2027. The adult-use (recreational) market will cover 67% of the spending; medical marijuana will take up the remaining 33%.
The largest group of cannabis buyers will be in North America, going from $9.2 billion in 2017 to $47.3 billion a decade later. The largest growth spread, however, is predicted within the rest-of-world markets, from $52 million spent in 2017 to a projected $2.5 billion in 2027.
The worldwide adult recreational cannabis market remains hampered by the United Nations and its 1961 Single Convention on Narcotic Drugs. The ArcView and BDS report believe nothing will be done to change the U.N. attitude until U.S. federal laws legalize marijuana — something Arcview’s CEO, Troy Dayton, believes will happen after the 2020 presidential election.
Still, the main difference between the U.S. and European cannabis markets is that in the U.S., recreational use will dominate sales. With a budget of $1.3 trillion in health care spending, European government-subsidized health care systems will bring the medical cannabis market to dominate Europe and become the largest medical marijuana market in the world.
BANGI believes that the future belongs to those who are keen on capitalizing on the biggest growth trends. We invite you to join us in capitalizing on the fastest growing industry in America.
(0)
(0)
